ConfirmMDx Improves Prostate Cancer Diagnosis in African American Men
Go back to ConfirmMDx Improves Prostate Cancer Diagnosis in African American Men| (NASDAQ: MDXH) | Delayed: 0.71 -0.01 (1.39%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $0.72 | 52 Week High | $ | |||
| Open | $0.71 | 52 Week Low | $ | |||
| Day High | $0.73 | P/E | N/A | |||
| Day Low | $0.71 | EPS | $ | |||
| Volume | 49,783 | |||||
